I have been sifting through some previous announcements,
April 28 - Update on Prochymal, mentions upcoming meeting with FDA to discuss potential accelerated pathways for Prochymal.
May 28 - Plans to Accelerate manufacturing operations in Singapore, preparing for product launch etc.
June 6 - Oncology - Recent discussions with the FDA have provided clarity on the pathway to a accelerated product approval in USA GVHD....
Additionally, proprietory manufacturing processes using large scale manufacturing bioreactors are in place to meet anticipated commercial growth.......
What could these announcements be telling us??
Good Luck
DYOR
I have been sifting through some previous announcements, April...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |